The 16 × 5.5 mm gallbladder calculus does not by itself indicate surgery. Cholecystectomy is indicated if the patient has typical biliary symptoms such as recurrent RUQ/epigastric postprandial pain, nausea/vomiting, or complications such as acute cholecystitis, pancreatitis, or choledocholithiasis. If asymptomatic, conservative management is appropriate.
The mildly elevated bilirubin (1.68 mg/dL) and GGT (56 U/L) may be related to transient biliary obstruction, but they are not sufficient to diagnose CBD stone. AST/ALT are not significantly elevated. Review the ultrasound specifically for CBD diameter and intrahepatic biliary dilatation. If CBD is dilated or cholestatic parameters remain elevated/worsen, MRCP/EUS should be considered to exclude choledocholithiasis. ERCP should be reserved for confirmed/high-probability CBD obstruction or cholangitis.
Grade-2 hepatomegaly may be associated with fatty
liver, but hepatomegaly alone does not confirm it. Assess hepatic steatosis on ultrasound and evaluate metabolic risk factors. Treatment is primarily lifestyle modification and management of metabolic risk factors.
The chronic bilateral pitting pedal edema is unlikely to be explained by the gallstone and requires separate evaluation for renal, cardiac, hepatic,
thyroid, medication-related and venous causes.
Next Steps
* Repeat
LFT: bilirubin, ALP, AST, ALT and GGT.
* Review ultrasound for CBD diameter, biliary dilatation and signs of cholecystitis.
* If CBD is normal and LFTs normalize → no MRCP/CT required.
* If CBD is dilated or LFTs remain/worsen → MRCP or EUS.
* If symptomatic gallstone disease is confirmed → plan elective laparoscopic cholecystectomy.
* Evaluate pedal edema with RFT/
electrolytes, serum
albumin, urine routine/protein,
TSH ± cardiac evaluation as clinically indicated.
* Assess for fatty
liver/metabolic dysfunction with BMI, glucose/
HbA1c and
lipid profile; calculate FIB-4 when platelet count is available.
Health Tips
The presence of a gallstone and mild bilirubin/GGT elevation should not automatically be interpreted as CBD obstruction. Avoid diagnostic ERCP without appropriate evidence because of its procedural risks.
Urgent evaluation is required if the patient develops jaundice, fever/chills, severe or persistent RUQ pain, vomiting, dark urine/pale stools, or worsening
liver-function tests, as these may suggest biliary obstruction or cholangitis.